Literature DB >> 11496115

Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain.

H Potschka1, W Löscher.   

Abstract

The mechanisms that lead to drug resistance in epilepsy are not known. Recently, overexpression of multidrug transporters, such as multidrug resistance-associated protein (MRP), has been reported in surgically resected epileptogenic human brain tissue and suggested to contribute to the drug resistance of epilepsy. However, it is not known to what extent multidrug transporters such as MRP are involved in transport of antiepileptic drugs. In the present study, we used in vivo microdialysis in rats to study whether the concentration of phenytoin in the extracellular fluid of the cerebral cortex can be enhanced by inhibition of MRP, using the MRP inhibitor probenecid. Local perfusion with probenecid via the microdialysis probe significantly enhanced the extracellular concentration of phenytoin. The data indicate that MRP critically participates in the regulation of extracellular brain concentrations of the major antiepileptic drug phenytoin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496115     DOI: 10.1097/00001756-200108080-00020

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

Review 1.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  NeuroRx       Date:  2005-01

Review 2.  Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Authors:  Sagar Agarwal; Ramola Sane; Rajneet Oberoi; John R Ohlfest; William F Elmquist
Journal:  Expert Rev Mol Med       Date:  2011-05-13       Impact factor: 5.600

3.  Somatosensory-related gamma-, beta- and alpha-augmentation precedes alpha- and beta-attenuation in humans.

Authors:  Miho Fukuda; Csaba Juhász; Karsten Hoechstetter; Sandeep Sood; Eishi Asano
Journal:  Clin Neurophysiol       Date:  2010-01-13       Impact factor: 3.708

4.  The Role of Drug-resistance Proteins in Medically Refractory Epilepsy.

Authors:  Jacqueline A. French
Journal:  Epilepsy Curr       Date:  2002-09       Impact factor: 7.872

5.  Focal epilepsy associated with glioneuronal tumors.

Authors:  Giulia Loiacono; Chiara Cirillo; Francesco Chiarelli; Alberto Verrotti
Journal:  ISRN Neurol       Date:  2011-07-07

6.  Significance of MDR1 and multiple drug resistance in refractory human epileptic brain.

Authors:  Nicola Marchi; Kerri L Hallene; Kelly M Kight; Luca Cucullo; Gabriel Moddel; William Bingaman; Gabriele Dini; Annamaria Vezzani; Damir Janigro
Journal:  BMC Med       Date:  2004-10-09       Impact factor: 8.775

7.  P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.

Authors:  Aimei Ma; Cuicui Wang; Yinghui Chen; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-12-03       Impact factor: 4.162

Review 8.  Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.

Authors:  Jie Xiong; Ding-An Mao; Li-Qun Liu
Journal:  Biomed Res Int       Date:  2015-09-27       Impact factor: 3.411

Review 9.  Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers.

Authors:  Fei Tang; Anika M S Hartz; Björn Bauer
Journal:  Front Neurol       Date:  2017-07-06       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.